Business and News Update June 2011


Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-06-01-2011
Volume 20
Issue 6

Industry news focusing on the people and organizations who work in the clinical trials profession.


• Bringing with him more than 25 years in the pharmaceutical, biotechnology, and CRO industries, James Dixon has been named Senior Vice President, Quality and Compliance at Cetero Research (Cary, NC).

James Dixon

• Novella Clinical (Research Triangle Park, NC) has made several changes to its team including the appointment of Richard Farris as Senior Director for Project Management and the promotion of Michael Doyle to Global Head of Regulatory Affairs.

Richard Farris

• Quanticate (Cambridge, MA) has appointed Robin Sutherland as Head of US Operations where she will be responsible for all aspects of business expansion across the United States and Canada.

Robin Sutherland

• Dawn Duggan has joined A10 Clinical Solutions (Cary, NC) as Director of Strategic Clinical Solutions where she will be responsible for strategically growing A10's presence within the northeastern US pharmaceutical and biotechnology hub.

Dawn Duggan

• ICON (Dublin, Ireland) has strengthened the leadership of its medical imaging division through the promotion of Kornelia Martin, PhD, as Vice President, European Operations, where she will be responsible for driving ICON medical imaging's activities in Europe, which were expanded through the acquisition of Timaq Medical Imaging in May 2010.

• Biomedical Research Alliance of New York (New York, NY) has made several additions to its team including Alexi Morillo as Program Director for Medicare coverage analysis and Maureen Hurst, as GCP Compliance Auditor.

• AAIPharma Services (Wilmington, NC) has appointed Paul Maffuid as Executive Vice President of Operations where he will be in charge of the company's drug product development services functions.

• Valerie Palumbo has joined PharmaNet Development Group (Princeton, NJ) as Senior Vice President, Corporate Quality Assurance.

Y. Hamied, PhD, Chairman of Cipla and Honorary Fellow of Christ’s College, Cambridge, and G. V. Prasad, Vice Chairman and CEO.


  • BioClinica's (Newtown, PA) Trident IWR (interactive web response) has been selected by seven new clients in the first quarter of 2011 to help build and deploy complex trials efficiently without the need for programming. Trident IWR provides clinical operations personnel a way to directly set up, monitor, and maintain randomization and supplies for their clinical trials.

  • Clearstone Central Laboratories (Ontario, Canada) announced that it has entered into a partnership with MitsubishiChemical Medience Corporation (Tokyo, Japan). This preferred provider relationship provides clients of both companies with access to CAP-accredited laboratories for safety and specialty testing services throughout the Asia-Pacific region. The cross-collaboration opens access for Mitsubishi clients to Clearstone's lab in China and to its global laboratory network, and creates a new solution for Clearstone clients to access Mitsubishi's lab network in Japan.

  • Velos (Fremont, CA) has formed an initiative with Comaiba (Fremont, CA), a company focused on regulatory monitoring, risk management, and incident management, to help customers increase efficiency and decrease risk as they interpret, document, and execute regulatory and clinical policies through their Velos-Comaiba Monitoring and Action solutions.

  • ICON (Dublin, Ireland) and ACRONET (Tokyo, Japan), a Japanese CRO, have signed an alliance agreement. Through the agreement, ICON and ACRONET will collaborate to offer global and Japanese pharmaceutical clients a full range of clinical development capabilities to manage trials on a regional or global basis.

  • Keio Center for Clinical Research (Tokyo, Japan), one of Japan's two centers of excellence promoting global clinical research, has chosen to standardize on Medidata Solutions' (New York, NY) Medidata Rave as its electronic data capture and clinical data management solution.


  • The Almac Group (Craigavon, Northern Ireland) was named "Business of the Year'" for the second time in three years at the Northern Ireland business awards, run by the nation's main daily newspaper, the Belfast Telegraph in association with British Midland International. Almac was recognized for its continued excellence in the field of contract drug development and manufacturing within the biotechnology and pharmaceutical sectors.

  • Clearstone Central Laboratories (Ontario, Canada) and Chiltern International (London, UK) have been selected by Eli Lilly and Company (Indianapolis, IN) for the 2010 Lilly Global Supplier Award. The Lilly Global Supplier Award is presented annually to suppliers who have provided Lilly with competitive edge and demonstrated a measurable impact on Lilly corporate priorities through the delivery of exemplary quality, service, speed, total cost reduction, and other value adds.

  • NextDocs (King of Prussia, PA) has been named the winner of the 2011 Bio-IT World Conference Best of Show in the Clinical Trials and Research category based on criteria for innovation, importance of problem/task being addressed, and excellence in technology which enables the life science research and development value chain.

  • Accelovance (Rockville, MD) has been named the "Best Contract Research Organization" for a third consecutive year. The World Vaccine Congress, held at the Gaylord National Hotel and Convention Center, Washington, DC, hosted its annual Vaccine Industry Excellence Awards to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry over the past 12 months.

  • ClinTec International (Glasgow, UK) has been named a recipient of the Queen's Award for Enterprise under the category of International Trade in recognition of its substantial growth in overseas revenue and commercial success in the last three years, achieving an increase in overseas sales in excess of 250 percent from 2007–2009.

  • Copernicus Group IRB (Research Triangle Park, NC) has been selected for the InfoWorld Green 15 awards. The InfoWorld Green 15 annual award recognizes the 15 most innovative IT initiatives that fall under the umbrella of sustainability. The Copernicius Group's shift from being paper-based to paperless has saved the organization more than $2 million on shipping, printing, postage, and file storage.

  • INC Research (Raleigh, NC) has been rated one of the world's top CROs in the 2011 CenterWatch Global Investigative Site Survey and earned a number nine ranking among CROs in CenterWatch's first global survey, which included input from clinical research professionals at investigative sites across 74 countries.

Company News

  • Clinilabs (New York, NY) has been selected to conduct a Phase I clinical research study of an investigational medication in subjects with Chronic Obstructive Pulmonary Disease as well as a Phase I clinical research study of an investigational medication in patients with Obstructive Sleep Apnea.

  • DaVita Clinical Research (DCR) (Minneapolis, MN) has completed its Phase I-IIa clean room to comply with USP 797 high risk regulations. DCR has demonstrated its clean room abides by the requirements set in place for the USP 797 high risk compliance and ensures its ability to handle compounds in a safe and efficient manner.

  • Premier Research Group (Philadelphia, PA) has re-branded its Medical Device business unit to D-TARGET.

  • Cardinal Health (Dublin, OH) has introduced extensive upgrades to and features a new, more user-friendly design and extensive new resources, providing online access to education resources, reimbursement information, and practice management and business tools.

  • ERT (Philadelphia, PA) has been awarded three new contracts with top tier pharmaceutical companies, totaling over $10 million for its electronic patient reported outcomes business.

  • Vetter's Chicago facility, located at the Illinois Science and Technology Park, is accepting client projects. The site supports preclinical through Phase II products and provides cGMP filling for vials, syringes, and cartridges.

  • Dr. Reddy's Laboratories has opened its newly expanded Chirotech Technology Center at Cambridge Science Park, UK where Chirotech has been based for the last 20 years. The new 33,000 sq. ft. facility is built for laboratories and offices and has been fitted to its specific requirements for chemistry, biology, and analytics.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.